How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Forbes contributors publish independent expert analyses and insights. William Arruda covers personal branding, leadership, and careers. Your LinkedIn headline plays the same role as the headline of an ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

As a group, these U.S. billionaires are richer than ever before. And the cutoff to make the list jumped more than it ever has. The richest person in America, for the fourth year in a row, is Jeff ...